Healthcare provider profile · identity verified

Ronald C Pawlowski, D.O.

Family Practice · HANOVER PARK, IL · NPI 1932273554

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	260	76
Alprazolam	Alprazolam	230	52
Amlodipine Besylate	Amlodipine Besylate	226	66
Metoprolol Succinate	Metoprolol Succinate	214	59
Pantoprazole Sodium	Pantoprazole Sodium	172	45
Levothyroxine Sodium	Levothyroxine Sodium	170	43
Lisinopril	Lisinopril	151	41
Meloxicam	Meloxicam	145	40
Zolpidem Tartrate	Zolpidem Tartrate	123	24
Escitalopram Oxalate	Escitalopram Oxalate	122	28
Metoprolol Tartrate	Metoprolol Tartrate	110	33
Allopurinol	Allopurinol	106	27
Glipizide Er	Glipizide	104	26
Tamsulosin Hcl	Tamsulosin Hcl	103	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	24
Atenolol	Atenolol	99	22
Lorazepam	Lorazepam	95	21
Furosemide	Furosemide	90	19
Gabapentin	Gabapentin	89	17
Simvastatin	Simvastatin	86	25
Hydrochlorothiazide	Hydrochlorothiazide	82	29
Rosuvastatin Calcium	Rosuvastatin Calcium	80	24
Metformin Hcl	Metformin Hcl	70	21
Sertraline Hcl	Sertraline Hcl	65	15
Azithromycin	Azithromycin	64	57
Clopidogrel	Clopidogrel Bisulfate	60	15
Amoxicillin	Amoxicillin	57	42
Acetaminophen-Codeine	Acetaminophen With Codeine	53	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	11
Enalapril Maleate	Enalapril Maleate	41	14
Metformin Hcl Er	Metformin Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	18
Eliquis	Apixaban	38	11
Finasteride	Finasteride	38	suppressed
Losartan Potassium	Losartan Potassium	38	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	31
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	30
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Methylprednisolone	Methylprednisolone	32	24
Omeprazole	Omeprazole	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	12
Synthroid	Levothyroxine Sodium	29	suppressed
Carvedilol	Carvedilol	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	18
Diazepam	Diazepam	25	suppressed
Pregabalin	Pregabalin	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cefdinir	Cefdinir	17	17
Cephalexin	Cephalexin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Prednisone	Prednisone	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Famotidine	Famotidine	15	suppressed
Glipizide	Glipizide	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nadolol	Nadolol	13	suppressed
Ramipril	Ramipril	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error